| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,897,146 | 1,901,818 | 1,808,006 | 1,800,306 | | Cost of Revenue | 1,097,535 | 1,100,212 | 1,053,489 | 1,040,925 | | | Gross Profit | 799,611 | 801,606 | 754,517 | 759,381 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 426,423 | 448,608 | 424,449 | 432,328 | | Non Recurring | 15,754 | (15,754) |
-
| 673 | | Others | 9,154 | 9,377 | 9,005 | 9,323 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 348,280 | 359,375 | 321,063 | 317,057 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,142 | (8,980) | (2,273) | (7,797) | | Earnings Before Interest And Taxes | 360,994 | 358,777 | 327,360 | 307,654 | | Interest Expense | 34,757 | 36,961 | 39,844 | 44,577 | | Income Before Tax | 326,237 | 321,816 | 287,516 | 263,077 | | Income Tax Expense | 125,145 | 123,535 | 110,189 | 93,481 | | Minority Interest | 18,723 | (18,723) |
-
| (8,221) | | | | Net Income From Continuing Ops | 219,815 | 179,558 | 177,327 | 169,596 | | | Non-recurring Events | | Discontinued Operations | 543 | 88 | (1,671) | 217 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 220,358 | 179,646 | 175,656 | 169,813 | | Preferred Stock And Other Adjustments | (28,139) | 8,554 | (8,554) |
-
| | | Net Income Applicable To Common Shares | $192,219 | $188,200 | $167,102 | $169,813 |
|
0.29% Nasdaq 
Income Statement
